Latest Coronavirus Disease COVID 19 News and Research
Drugmakers tout COVID-19 vaccines to refurbish their public image
Johnson & Johnson researchers working on a vaccine against the coronavirus are "just like the heroes in the hospitals" fighting to save patients, J&J CEO Alex Gorsky said on the "Today" show a few weeks ago.
Medicaid providers at the end of the line for federal COVID funding
Casa de Salud, a nonprofit clinic in Albuquerque, New Mexico, provides primary medical care, opioid addiction services and non-Western therapies, including acupuncture and reiki, to a largely low-income population.
New biodegradable antiviral filters developed for protective masks
The CSIC's associated unit in Polymer Technology in Castellón will study the biodegradation levels of the materials developed.
Researchers are developing advanced measures to fight against COVID-types contagions
A research team from the University of Valencia, led by the professor of the Department of Computer Science Pedro Morillo, is developing a project to improve protection against infections in areas of high availability of health centres.
Research explores how human enzymes could be used to exacerbate COVID-19
Centenary Institute researchers have examined the critical role of human enzymes and the coronavirus in a newly published scientific review article that explores potential strategies for COVID-19 disease treatment and management.
Interactive "Netflix" type platform for educators affected by COVID-19
The World Literacy Foundation announced today the development of an interactive "Netflix" type platform to equip educators with resources that have been affected by the indefinite school lockdown as a result of COVID-19.
Oxford University vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
As the world continues to grapple with the coronavirus pandemic, many scientists, institutions, and pharmaceutical companies are working hard to develop an effective vaccine.
IDT opens new manufacturing facility to expand capacity of COVID-19 products
Integrated DNA Technologies, a leading comprehensive genomics solutions provider, announced the opening of its new manufacturing facility located in the Research Triangle Park in North Carolina.
Protective Film Solutions donates over 5,500 protective visors to key workers
Suppliers of protective glass window films, Protective Film Solutions, has donated more than 5,500 pieces of personal protective equipment to hospitals, care homes and other medical facilities across the country, to prevent the spread of COVID-19.
Kawasaki disease outbreak in children with COVID-19
The ongoing COVID-19 pandemic has marched its way to almost all parts of the world, with hundreds of thousands of deaths and over 4.5 million cases as of May 15, 2020. One saving grace has been the apparent sparing of children, though the mortality in older people is quite high.
Host-virus interaction drives adaptive mutation in bat CoV related to SARS-CoVs
Virus and receptor diversity is shaped by the need to evolve advanced weaponry to facilitate virus entry and infection, on the one hand, and host resistance, on the other. A new paper published on the preprint server bioRxiv* shows how this mechanism operates in a bat coronavirus, which is related to the earlier SARS coronavirus.
Staggered local re-openings could be the best COVID-19 exit strategy
When a new infectious disease appears, the lack of an effective treatment or vaccine strategy often results in the application of non-pharmacological interventions (NPIs) or containment measures, including testing for infection, tracing contacts, and isolating potential sources of infection.
Inadequate vaccine and epidemic control in the US
A new paper published on the preprint server medRxiv* in May 2020 shows that vaccination must be combined with nonpharmacological interventions (NPIs) to achieve rapid and effective control of the ongoing pandemic.
Researchers investigate safety of convalescent plasma for COVID-19
The current pandemic of COVID-19 seems to be slowing down in various parts of the world, but is far from controlled, as incidence rates rise in new regions. In the absence of an effective vaccine or therapeutic drug, scientists have relied on supportive medical care to treat the sick.
New and unexplored angle in the binding of SARS-CoV-2 to host cells
Researchers in the Netherlands, Cuba, and Italy have made important discoveries about the carbohydrate-mediated binding of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein to host cell lectin receptors and host lung microbiota.
Well-known cancer drugs may prevent SARS-CoV-2 viral replication say researchers
Researchers in Frankfurt, Germany, have described cell signaling events that occur when severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects host cells and have identified pathways that are essential for the virus to replicate.
Study shows human monoclonal antibodies can effectively neutralize SARS-CoV-2
US researchers have published a proof of concept on the efficacy of human monoclonal antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in laboratory conditions, as well as their pioneering use in a mouse model. The study is available on the preprint server bioRxiv*.
Study shows broad geographic and evolutionary dispersal of betacoronaviruses from African bats
A research group from Nigeria found evidence of long-distance transmission and dispersal between bat coronaviruses isolated in Africa and the ones Europe and Asia, as described in a new paper available on the preprint server bioRxiv.
Collective isolation is the most viable strategy for minimizing COVID-19 in indigenous populations
A team of anthropologists, physicians, tribal leaders and local government authorities developed and implemented a multi-phase COVID-19 prevention and containment plan among the Tsimane, an indigenous group of forager-horticulturists in the Bolivian Amazon.
Study: U.S. COVID-19 cases could have been much higher without social distancing measures
As stay-at-home orders are being lifted in some states and extended in others, uncertainty continues to surround the COVID-19 pandemic.
No hay comentarios:
Publicar un comentario